Literature DB >> 23139608

High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease.

Edith Lahner1, Gianluca Esposito, Angelo Zullo, Cesare Hassan, Claudio Cannaviello, Maria Carla Di Paolo, Lorella Pallotta, Nicoletta Garbagna, Enzo Grossi, Bruno Annibale.   

Abstract

AIM: To investigate in symptomatic uncomplicated diverticular disease the efficacy of symbiotics associated with a high-fibre diet on abdominal symptoms.
METHODS: This study was a multicentre, 6-mo randomized, controlled, parallel-group intervention with a preceding 4-wk washout period. Consecutive outpatients with symptomatic uncomplicated diverticular disease, aged 40-80 years, evaluated in 4 Gastroenterology Units, were enrolled. Symptomatic uncomplicated diverticular disease patients were randomized to two treatment arms A or B. Treatment A (n = 24 patients) received 1 symbiotic sachet Flortec(©) (Lactobacillus paracasei B21060) once daily plus high-fibre diet for 6 mo. Treatment B (n = 21 patients) received high-fibre diet alone for 6 mo. The primary endpoint was regression of abdominal symptoms and change of symptom severity after 3 and 6 mo of treatment.
RESULTS: In group A, the proportion of patients with abdominal pain < 24 h decreased from 100% at baseline to 35% and 25% after 3 and 6 mo, respectively (P < 0.001). In group B the proportion of patients with this symptom decreased from 90.5% at baseline to 61.9% and 38.1% after 3 and 6 mo, respectively (P = 0.001). Symptom improvement became statistically significant at 3 and 6 mo in group A and B, respectively.The proportion of patients with abdominal pain >24 h decreased from 60% to 20% then 5% after 3 and 6 mo, respectively in group A (P < 0.001) and from 33.3% to 9.5% at both 3 and 6 mo in group B (P = 0.03). In group A the proportion of patients with abdominal bloating significantly decreased from 95% to 60% after 3 mo, and remained stable (65%) at 6-mo follow-up (P = 0.005) while in group B, no significant changes in abdominal bloating was observed (P = 0.11). After 6 mo of treatment, the mean visual analogic scale (VAS) values of both short-lasting abdominal pain (VAS, mean ± SD, group A: 4.6 ± 2.1 vs 2.2 ± 0.8, P = 0.02; group B: 4.6 ± 2.9 vs 2.0 ± 1.9, P = 0.03) and abdominal bloating (VAS, mean ± SD, group A: 5.3 ± 2.2 vs 3.0 ± 1.7, P = 0.005; group B: 5.3 ± 3.2 vs 2.3 ± 1.9, P = 0.006) decreased in both groups, whilst the VAS values of prolonged abdominal pain decreased in the Flortec(©) group, but remained unchanged in the high-fibre diet group (VAS, mean ± SD, group A: 6.5 ± 1.5 vs 4.5 ± 2.1, P = 0.052; group B: 4.5 ± 3.8 vs 5.5 ± 3.5).
CONCLUSION: A high-fibre diet is effective in relieving abdominal symptoms in symptomatic uncomplicated diverticular disease. This treatment may be implemented by combining the high-fibre diet with Flortec(©).

Entities:  

Keywords:  Diverticular disease; High-fibre diet; Lactobacillus paracasei B21060; Probiotics; Symbiotics; Symptomatic uncomplicated diverticular disease

Mesh:

Year:  2012        PMID: 23139608      PMCID: PMC3491599          DOI: 10.3748/wjg.v18.i41.5918

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology.

Authors:  N H Stollman; J B Raskin
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

2.  Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.

Authors:  Antonio Tursi; Giovanni Brandimarte; Gian Marco Giorgetti; Walter Elisei
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

3.  Cluster randomized controlled trials in primary care: an introduction.

Authors:  Andrew W Murphy; Adrian Esterman; Louis S Pilotto
Journal:  Eur J Gen Pract       Date:  2006       Impact factor: 1.904

Review 4.  Role of probiotics in management of diverticular disease.

Authors:  Neeraj Narula; John K Marshall
Journal:  J Gastroenterol Hepatol       Date:  2010-12       Impact factor: 4.029

Review 5.  The pathology of diverticular disease.

Authors:  Linmarie Ludeman; Bryan F Warren; Neil A Shepherd
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-08       Impact factor: 3.043

6.  Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease.

Authors:  D P Burkitt; A R Walker; N S Painter
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

7.  Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with acute diarrhea: a multicenter, randomized study in primary care.

Authors:  Enzo Grossi; Roberto Buresta; Roberto Abbiati; Renata Cerutti
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

Review 8.  Probiotics and gastrointestinal diseases.

Authors:  A Sullivan; C E Nord
Journal:  J Intern Med       Date:  2005-01       Impact factor: 8.989

9.  The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon.

Authors:  Pruemysl Fric; Miroslav Zavoral
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 2.566

Review 10.  Diverticular disease of the colon.

Authors:  Neil Stollman; Jeffrey B Raskin
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  7 in total

Review 1.  Dietary Fiber and Gastrointestinal Disease: an Evolving Story.

Authors:  John O'Grady; Fergus Shanahan
Journal:  Curr Gastroenterol Rep       Date:  2018-11-08

2.  Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines.

Authors:  G A Binda; R Cuomo; A Laghi; R Nascimbeni; A Serventi; D Bellini; P Gervaz; B Annibale
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

3.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

Review 4.  Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.

Authors:  Eleonora Scaioli; Antonio Colecchia; Giovanni Marasco; Ramona Schiumerini; Davide Festi
Journal:  Dig Dis Sci       Date:  2015-10-12       Impact factor: 3.199

Review 5.  Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis.

Authors:  Walter Elisei; Antonio Tursi
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

Review 6.  Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review.

Authors:  Marilia Carabotti; Bruno Annibale; Carola Severi; Edith Lahner
Journal:  Nutrients       Date:  2017-02-20       Impact factor: 5.717

7.  Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort.

Authors:  Adi Lahat; Herma H Fidder; Shomron Ben-Horin
Journal:  Therap Adv Gastroenterol       Date:  2020-05-08       Impact factor: 4.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.